Phase IV trial data with Rayaldee shows efficacy in chronic kidney disease.- OPKO Health
OPKO Health reported interim results from an ongoing Phase IV clinical trial comparing Rayaldee with three common treatment regimens for secondary hyperparathyroidism (SHPT) in adult patients with stage… read more.